Weaver Capital Management LLC raised its position in Danaher Corporation (NYSE:DHR – Free Report) by 1,311.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,358 shares of the conglomerate’s stock after acquiring an additional 17,057 shares during the quarter. Weaver Capital Management LLC’s holdings in Danaher were worth $4,067,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. EP Wealth Advisors LLC purchased a new position in shares of Danaher during the 2nd quarter valued at about $3,807,000. Puzo Michael J bought a new position in shares of Danaher during the 2nd quarter valued at approximately $8,624,000. Madison Asset Management LLC bought a new position in shares of Danaher during the 2nd quarter valued at approximately $85,451,000. First Nebraska Trust Co bought a new position in shares of Danaher during the 2nd quarter valued at approximately $14,106,000. Finally, Colton Groome Financial Advisors LLC purchased a new stake in Danaher in the 3rd quarter worth approximately $592,000. Institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
NYSE:DHR opened at $231.52 on Friday. The business’s 50-day simple moving average is $213.55 and its two-hundred day simple moving average is $195.74. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a market cap of $162.76 billion, a PE ratio of 41.12, a P/E/G ratio of 2.82 and a beta of 0.76. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 earnings per share. As a group, analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is 28.42%.
Wall Street Analyst Weigh In
DHR has been the topic of a number of recent analyst reports. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. Morgan Stanley lifted their price target on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a report on Monday. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Royal Bank Of Canada upped their price target on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a research report on Monday, October 5th. Finally, TD Cowen increased their price objective on shares of Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a research note on Tuesday. Two research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $235.41.
View Our Latest Report on Danaher
Danaher News Roundup
Here are the key news stories impacting Danaher this week:
- Positive Sentiment: Danaher and NVIDIA announced an AI collaboration to combine Danaher’s scientific instruments, laboratory workflows, automation technology and software with NVIDIA’s accelerated computing and AI capabilities. The partnership is intended to advance autonomous science and speed drug discovery and other laboratory research. Danaher Collaborates with NVIDIA to Advance Autonomous Science
- Positive Sentiment: Danaher is also preparing to launch its first AI-powered autonomous laboratory, targeted to operate at commercial scale in early 2027. The initiative could support longer-term growth in laboratory automation and strengthen the company’s position in AI-enabled life-science research. How to Invest in AI Drug Discovery
- Positive Sentiment: Multiple Zacks reports say Danaher has a favorable combination of earnings-estimate trends and Earnings ESP, suggesting potential for the company to exceed consensus estimates in its next quarterly report. Danaher has also recently demonstrated earnings momentum, with its latest reported quarter exceeding both EPS and revenue expectations. Will Danaher Beat Estimates Again in Its Next Earnings Report?
- Neutral Sentiment: Danaher is projected to announce earnings on Wednesday. Investors will be watching revenue growth, management’s outlook and whether diagnostics and life-sciences demand support the anticipated improvement in earnings. Danaher Projected to Announce Earnings
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
Featured Stories
- Five stocks we like better than Danaher
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
